Welcome to our dedicated page for Veradigm news (Ticker: MDRX), a resource for investors and traders seeking the latest updates and insights on Veradigm stock.
Veradigm Inc. (MDRX) is a healthcare technology company that focuses on healthcare data and technology solutions for providers, payers, and biopharma organizations. News about Veradigm often centers on how the company uses its platforms, data, connectivity, and expertise within the Veradigm Network to support clinical, operational, and financial performance in healthcare.
Investors and industry observers following MDRX news can expect updates on business performance, financing, and capital structure, as reflected in Veradigm’s announcements about financial outlooks, cash and debt levels, and debt financing arrangements. The company also issues news about its progress on financial reporting, including the filing of its Annual Report on Form 10-K with restated financial statements and its efforts to become current in SEC filings and pursue relisting on a national stock exchange.
Operational and client-focused news includes case studies and collaborations that highlight Veradigm’s role in value-based care, payer–provider integration, and revenue cycle management. Examples include recognition through a KLAS Points of Light Award for delivering insights at the point of care and announcements about organizations selecting Veradigm Revenue Cycle Services, Coding Services, and related offerings such as Veradigm Revenue Analytics, Veradigm Practice Management, and Veradigm Payerpath.
Veradigm also issues news on product and capability developments, such as applying artificial intelligence to deidentified EHR data to generate real-world evidence for GLP-1 therapies, and on thought leadership initiatives like the Smart Medicine Podcast. Governance and corporate updates, including leadership appointments and amendments to the company’s stockholder rights plan, are additional recurring themes. For a comprehensive view of MDRX-related developments, this news page aggregates these announcements and related coverage in one place.
Allscripts Healthcare Solutions (MDRX) has announced its preliminary financial results for Q4 and the full year ended December 31, 2021. Revenue for Q4 is projected at $390M-$395M, while the full year GAAP operating income is expected between $70M and $75M. The company anticipates Adjusted EBITDA of $295M-$300M, exceeding previous guidance. Cash flow from continuing operations is expected at $245M-$250M, with free cash flow at $165M-$170M. Additionally, Allscripts has approved a new share repurchase program of up to $250M, replacing its previous $350M program.
Allscripts (NASDAQ: MDRX) has partnered with Next Level Urgent Care to implement its TouchWorks® electronic health record (EHR) platform across all their Houston locations. This initiative aims to enhance EHR workflows, improve analytics, and streamline patient care. With Next Level being Texas's first accredited urgent care center, the integration of Allscripts' solutions and Microsoft Azure services is expected to promote quality healthcare. The partnership underscores Allscripts' commitment to driving better clinical outcomes and operational efficiencies.
Allscripts Healthcare Solutions (Nasdaq: MDRX) reported significant financial growth for Q3 2021, with GAAP diluted EPS of $0.12 and non-GAAP diluted EPS of $0.27, marking a 145% increase year-over-year. The company generated $57 million in cash flow from continuing operations and $35 million in free cash flow. Total bookings reached $166 million, up from $160 million in Q3 2020, while revenue increased to $369 million compared to $366 million in the previous year. Allscripts has revised its 2021 Adjusted EBITDA outlook to between $275 million and $285 million.
Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) will release its financial results for Q3 2021 on November 4, 2021, after market close. A conference call to discuss these results is scheduled for 4:30 p.m. ET on the same day. Interested participants can join via the Allscripts Investor Relations website or by phone. A replay will be accessible shortly after the call for four weeks. Allscripts is a leader in healthcare IT solutions, focusing on enhancing clinical, financial, and operational outcomes within the healthcare sector.
Allscripts has launched Guided Scheduling, an AI-powered scheduling application for Practice Management clients, aiming to optimize patient visits using real-time data. This tool enhances scheduling efficiency, reduces no-shows, and helps onboard new staff more quickly, as confirmed by Tracy E. Lyons from The Orthopedic Center. The solution is seamlessly integrated into existing workflows and supports various administrative automation features. The initiative represents Allscripts' commitment to improving healthcare operations through innovation and technology.
Seminal Capital Holdings announces key appointments to its Seminal Healthcare team, including Victor Kats, Mark Miller, and Lindsey Watson. These professionals bring extensive experience in healthcare technology and investment. Kats, with over 25 years in the industry, previously led the Healthcare Technology Practice at Ascension Ventures. Miller and Watson also come with a wealth of expertise from notable firms. Seminal Healthcare aims to enhance its impact investing focus and provide strategic support to healthcare companies.
Veradigm and CareMetx announced a new partnership to enhance the specialty medication approval process. The integration will allow CareMetx clients to access Veradigm's AccelRx automated solutions directly, aiming to reduce patient wait times and streamline administrative burdens. A 2020 survey indicated that 90% of physicians believe easier prescription fulfillment improves adherence, highlighting the importance of this collaboration. This partnership aligns with Veradigm's commitment to transforming healthcare delivery and improving patient outcomes.
Allscripts (NASDAQ: MDRX) has been selected as an innovation partner by Eastern Health, the largest health authority in Newfoundland and Labrador. This partnership aims to enhance healthcare services, improve patient care, and promote economic development in the region. The collaboration will leverage Allscripts' Open Development Program, allowing local developers and startups to innovate within its healthcare platform. Both entities are committed to improving health system efficiencies and creating new solutions that benefit patients and the broader healthcare community.
Allscripts (NASDAQ: MDRX) held the Advancing Health Equity Using Social Determinants of Health Developer Challenge, emphasizing the importance of sharing social determinants of health (SDOH) information to improve healthcare equity. Keynote speaker Dr. Micky Tripathi discussed efforts to combat health inequities. Eight developers presented solutions aimed at enhancing care through SDOH data integration. The challenge was won by Patient Orator, which aims to bridge the communication gap between patients and providers. Allscripts continues to innovate in healthcare technology to facilitate better patient outcomes.
Allscripts Healthcare Solutions (MDRX) reported a strong financial performance for Q2 2021, achieving bookings of $180 million, up from $164 million in Q2 2020. Revenue rose slightly to $374 million, with GAAP net income of $22 million compared to a loss of $8 million the previous year. Non-GAAP diluted earnings per share increased to $0.23 from $0.17. Adjusted EBITDA grew to $69 million, reflecting improved operational efficiency. The company revised its 2021 guidance, raising expected adjusted EBITDA to between $265-$275 million and free cash flow to $115-$125 million, while affirming revenue expectations of $1.5 billion.